Assessment of the feed additive copper bislysinate for all animal species for the renewal of its authorisation (Senzyme GmbH)

Assessment of the feed additive copper bislysinate for all animal species for the renewal of its authorisation (Senzyme GmbH)

Abstract Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the safety and efficacy of copper bislysinate as nutritional feed additive for all species and categories. The additive is currently authorised for use in all animal species (3b411). The appl...

Full description

Saved in:
Bibliographic Details
Main Authors: EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Roberto Edoardo Villa, Giovanna Azimonti, Eleftherios Bonos, Henrik Christensen, Mojca Durjava, Birgit Dusemund, Ronette Gehring, Boet Glandorf, Maryline Kouba, Marta López‐Alonso, Francesca Marcon, Carlo Nebbia, Alena Pechová, Miguel Prieto‐Maradona, Ilen Röhe, Katerina Theodoridou, Jaume Galobart, Fabiola Pizzo, Jordi Tarrés‐Call, Maria Vittoria Vettori, Alberto Navarro‐Villa
Format: Article
Language:English
Published: Wiley 2025-04-01
Series:EFSA Journal
Subjects:
copper bislysinate
efficacy
functional group: Compounds of trace elements; nutritional additives
safety
Online Access:https://doi.org/10.2903/j.efsa.2025.9356
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the safety and efficacy of copper bislysinate as nutritional feed additive for all species and categories. The additive is currently authorised for use in all animal species (3b411). The applicant has provided evidence that the additive, in powder or granule forms, complies with the conditions of the authorisation. The Panel on Additives and Products or Substances used in Animal Feed (FEEDAP Panel) confirms that the use of copper bislysinate under the current authorised conditions of use is safe for the target species, consumers and the environment. Regarding user safety, both forms of the additive are not irritant to the skin, but the powder product is an eye irritant. Both forms of the additive should be considered skin and respiratory sensitisers. Inhalation and dermal exposure are considered a risk. There is no need for assessing the efficacy of the additive in the context of the renewal of the authorisation.
ISSN:1831-4732

Similar Items